PID BETA CATENIN NUC PATHWAY |
80 |
60 |
All SZGR 2.0 genes in this pathway |
REACTOME DEVELOPMENTAL BIOLOGY |
396 |
292 |
All SZGR 2.0 genes in this pathway |
Reactome糖尿病途径 |
133 |
91 |
All SZGR 2.0 genes in this pathway |
REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN |
16 |
11 |
All SZGR 2.0 genes in this pathway |
白色脂肪细胞分化的Reactome转录调节 |
72 |
53 |
All SZGR 2.0 genes in this pathway |
Piccaluga血管免疫细胞淋巴瘤DN |
136 |
86 |
All SZGR 2.0 genes in this pathway |
Chemnitz对前列腺素E2 DN的反应 |
391 |
222 |
All SZGR 2.0 genes in this pathway |
IGARASHI ATF4 TARGETS DN |
90 |
65 |
All SZGR 2.0 genes in this pathway |
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP |
255 |
177 |
All SZGR 2.0 genes in this pathway |
Fulcher炎症反应凝集素与LPS DN |
463 |
290 |
All SZGR 2.0 genes in this pathway |
迪亚兹慢性巨型性白血病DN |
116 |
79 |
All SZGR 2.0 genes in this pathway |
Casorelli apl Secondary vs de从头上升 |
39 |
25 |
All SZGR 2.0 genes in this pathway |
deurig t细胞促进性白血病 |
368 |
234 |
All SZGR 2.0 genes in this pathway |
Horiuchi WTAP靶向 |
306 |
188 |
All SZGR 2.0 genes in this pathway |
JAEGER METASTASIS DN |
258 |
141 |
All SZGR 2.0 genes in this pathway |
胶原蛋白凝胶中的Oswald造血干细胞 |
233 |
161 |
All SZGR 2.0 genes in this pathway |
Gargalovic对氧化磷脂的反应黄色 |
32 |
25 |
All SZGR 2.0 genes in this pathway |
Bilban B Cll LPL DN |
42 |
25 |
All SZGR 2.0 genes in this pathway |
莱茵所有糖皮质激素治疗DN |
362 |
238 |
All SZGR 2.0 genes in this pathway |
UDayakumar Med1靶向DN |
240 |
171 |
All SZGR 2.0 genes in this pathway |
ZHOU INFLAMMATORY RESPONSE LPS UP |
431 |
237 |
All SZGR 2.0 genes in this pathway |
JAATINEN HEMATOPOIETIC STEM CELL DN |
226 |
132 |
All SZGR 2.0 genes in this pathway |
HAHTOLA MYCOSIS FUNGOIDES CD4 UP |
64 |
46 |
All SZGR 2.0 genes in this pathway |
刘cdx2靶向 |
36 |
22 |
All SZGR 2.0 genes in this pathway |
LANDIS BREAST CANCER PROGRESSION DN |
70 |
43 |
All SZGR 2.0 genes in this pathway |
GESERICK TERT TARGETS DN |
21 |
16 |
All SZGR 2.0 genes in this pathway |
chiaradonna肿瘤转化CDC25 DN |
153 |
100 |
All SZGR 2.0 genes in this pathway |
Markey RB1慢性洛夫 |
115 |
78 |
All SZGR 2.0 genes in this pathway |
VANHARANTA UTERINE FIBROID DN |
67 |
45 |
All SZGR 2.0 genes in this pathway |
Landis Erbb2乳腺肿瘤65 DN |
37 |
22 |
All SZGR 2.0 genes in this pathway |
Landis Erbb2乳腺肿瘤324 DN |
149 |
93 |
All SZGR 2.0 genes in this pathway |
berenjeno由Rhoa Up Troment |
536 |
340 |
All SZGR 2.0 genes in this pathway |
RASHI RESPONSE TO IONIZING RADIATION 2 |
127 |
92 |
All SZGR 2.0 genes in this pathway |
LINDGREN BLADDER CANCER CLUSTER 2B |
392 |
251 |
All SZGR 2.0 genes in this pathway |
SCHLOSSER SERUM RESPONSE DN |
712 |
443 |
All SZGR 2.0 genes in this pathway |
Mattioli多发性骨髓瘤,有14q32易位 |
36 |
25 |
All SZGR 2.0 genes in this pathway |
Seitz肿瘤转化通过8p删除 |
73 |
47 |
All SZGR 2.0 genes in this pathway |
ETS1和SP100 DN的Yordy倒数调节 |
87 |
48 |
All SZGR 2.0 genes in this pathway |
Gruetzmann胰腺癌 |
358 |
245 |
All SZGR 2.0 genes in this pathway |
TSAI RESPONSE TO IONIZING RADIATION |
149 |
101 |
All SZGR 2.0 genes in this pathway |
HOWLIN PUBERTAL MAMMARY GLAND |
69 |
40 |
All SZGR 2.0 genes in this pathway |
Schlesinger甲基化的癌症 |
88 |
64 |
All SZGR 2.0 genes in this pathway |
通过ELK3 DN的缺氧总缺氧 |
156 |
106 |
All SZGR 2.0 genes in this pathway |
通过HIF1A DN的缺氧总缺氧 |
110 |
78 |
All SZGR 2.0 genes in this pathway |
GROSS HYPOXIA VIA ELK3 AND HIF1A UP |
142 |
104 |
All SZGR 2.0 genes in this pathway |
Nuytten EZH2靶向 |
1037 |
673 |
All SZGR 2.0 genes in this pathway |
Ingram SHH目标 |
127 |
79 |
All SZGR 2.0 genes in this pathway |
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP |
811 |
508 |
All SZGR 2.0 genes in this pathway |
gotzmann上皮到间充质过渡dn |
206 |
136 |
All SZGR 2.0 genes in this pathway |
BENPORATH SUZ12 TARGETS |
1038 |
678 |
All SZGR 2.0 genes in this pathway |
Benporath EED目标 |
1062 |
725 |
All SZGR 2.0 genes in this pathway |
BENPORATH ES WITH H3K27ME3 |
1118 |
744 |
All SZGR 2.0 genes in this pathway |
BENPORATH PRC2 TARGETS |
652 |
441 |
All SZGR 2.0 genes in this pathway |
阿米特血清反应120 MCF10A |
65 |
44 |
All SZGR 2.0 genes in this pathway |
Onder CDH1目标2向上 |
256 |
159 |
All SZGR 2.0 genes in this pathway |
NELSON RESPONSE TO ANDROGEN UP |
86 |
61 |
All SZGR 2.0 genes in this pathway |
Zhan多发性骨髓瘤CD1 vs CD2 UP |
66 |
47 |
All SZGR 2.0 genes in this pathway |
MATSUDA NATURAL KILLER DIFFERENTIATION |
475 |
313 |
All SZGR 2.0 genes in this pathway |
HASLINGER B CLL WITH 13Q14 DELETION |
24 |
18 |
All SZGR 2.0 genes in this pathway |
HOXA9和MEIS1 DN的HESS目标 |
77 |
48 |
All SZGR 2.0 genes in this pathway |
GERY CEBP TARGETS |
126 |
90 |
All SZGR 2.0 genes in this pathway |
NGUYEN NOTCH1 TARGETS DN |
86 |
67 |
All SZGR 2.0 genes in this pathway |
量缺氧 |
98 |
71 |
All SZGR 2.0 genes in this pathway |
CUI TCF21 TARGETS 2 DN |
830 |
547 |
All SZGR 2.0 genes in this pathway |
GEORGANTAS HSC MARKERS |
71 |
47 |
All SZGR 2.0 genes in this pathway |
伯顿成年时期峰值2小时 |
51 |
36 |
All SZGR 2.0 genes in this pathway |
MCCLUNG COCAIN REWARD 4WK |
75 |
47 |
All SZGR 2.0 genes in this pathway |
杰克逊DNMT1靶向 |
77 |
57 |
All SZGR 2.0 genes in this pathway |
盖斯对dsrna的响应 |
38 |
29 |
All SZGR 2.0 genes in this pathway |
伊万诺娃造血细胞和祖细胞 |
681 |
420 |
All SZGR 2.0 genes in this pathway |
伯顿成生成9 |
92 |
59 |
All SZGR 2.0 genes in this pathway |
Krige对Tosedostat 6小时的反应 |
953 |
554 |
All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP |
783 |
442 |
All SZGR 2.0 genes in this pathway |
RIGGINS TAMOXIFEN RESISTANCE DN |
220 |
147 |
All SZGR 2.0 genes in this pathway |
海勒被甲基化沉默 |
282 |
183 |
All SZGR 2.0 genes in this pathway |
Massarweh tamoxifen抗性 |
578 |
341 |
All SZGR 2.0 genes in this pathway |
Iwanaga癌变由Kras Pten DN |
353 |
226 |
All SZGR 2.0 genes in this pathway |
iwanaga癌变由KRAS DN |
120 |
81 |
All SZGR 2.0 genes in this pathway |
MITSIADES RESPONSE TO APLIDIN UP |
439 |
257 |
All SZGR 2.0 genes in this pathway |
Boquest干细胞培养与新鲜 |
425 |
298 |
All SZGR 2.0 genes in this pathway |
LABBE TARGETS OF TGFB1 AND WNT3A DN |
108 |
68 |
All SZGR 2.0 genes in this pathway |
BRUECKNER TARGETS OF MIRLET7A3 UP |
111 |
69 |
All SZGR 2.0 genes in this pathway |
CONRAD STEM CELL |
39 |
27 |
All SZGR 2.0 genes in this pathway |
WU被膀胱癌中的甲基化沉默 |
55 |
42 |
All SZGR 2.0 genes in this pathway |
甜肺癌Kras DN |
435 |
289 |
All SZGR 2.0 genes in this pathway |
张TLX目标36hr |
221 |
150 |
All SZGR 2.0 genes in this pathway |
ZHANG TLX TARGETS 60HR UP |
293 |
203 |
All SZGR 2.0 genes in this pathway |
张TLX目标 |
108 |
78 |
All SZGR 2.0 genes in this pathway |
Meissner Brain HCP带有H3K4ME3和H3K27ME3 |
1069 |
729 |
All SZGR 2.0 genes in this pathway |
Schoen NFKB信号 |
34 |
26 |
All SZGR 2.0 genes in this pathway |
fontaine卵泡甲状腺腺瘤DN |
68 |
45 |
All SZGR 2.0 genes in this pathway |
fontaine乳头状甲状腺癌 |
66 |
38 |
All SZGR 2.0 genes in this pathway |
Uzonyi对白三烯和凝血酶的反应 |
37 |
26 |
All SZGR 2.0 genes in this pathway |
由MYC DN监管 |
253 |
192 |
All SZGR 2.0 genes in this pathway |
WONG ADULT TISSUE STEM MODULE |
721 |
492 |
All SZGR 2.0 genes in this pathway |
钱德兰转移DN |
306 |
191 |
All SZGR 2.0 genes in this pathway |
么时间响应黄体酮集群5 |
30 |
22 |
All SZGR 2.0 genes in this pathway |
Johnstone Parvb目标3 |
430 |
288 |
All SZGR 2.0 genes in this pathway |
PASINI SUZ12 TARGETS UP |
112 |
65 |
All SZGR 2.0 genes in this pathway |
DURAND STROMA NS UP |
162 |
103 |
All SZGR 2.0 genes in this pathway |
Zwang 3类由EGF瞬时诱导 |
222 |
159 |
All SZGR 2.0 genes in this pathway |